Astera Labs (NASDAQ:ALAB) Director Manuel Alba Sells 183,000 Shares

Astera Labs, Inc. (NASDAQ:ALAB) Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director directly owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Manuel Alba also recently made the following trade(s):

• On Wednesday, July 1st, Manuel Alba sold 136,974 shares of Astera Labs stock. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74.
• On Wednesday, July 1st, Manuel Alba sold 37,535 shares of Astera Labs stock. The stock was sold at an average price of $447.39, for a total transaction of $16,792,783.65.
• On Wednesday, July 1st, Manuel Alba sold 8,491 shares of Astera Labs stock. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58.

Astera Labs Price Performance

Shares of Astera Labs stock traded up $8.69 on Thursday, hitting $282.82. The company had a trading volume of 2,785,831 shares, compared to its average volume of 5,307,284. The business has a 50-day simple moving average of $334.67 and a 200-day simple moving average of $252.89. The company has a market cap of $49.07 billion, a PE ratio of 140.01 and a beta of 3.77. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the stock. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Astera Labs during the fourth quarter valued at approximately $18,708,000. Swedbank AB lifted its position in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in Astera Labs in the 4th quarter worth approximately $499,000. Revere Asset Management Inc acquired a new position in Astera Labs in the 4th quarter worth approximately $589,000. Finally, Banque Cantonale Vaudoise grew its position in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock worth $766,000 after purchasing an additional 3,229 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Needham & Company LLC upped their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Citigroup restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.